Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Biology » Physiology » Aerobic Exercise: Health Benefits, Types and Common Misconceptions Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Children's Issues and Challenges - CRS Reports from 2017 to 2018
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136)
Tell A Friend
Tell someone you know about this product.
Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136) $0.00
Authors:  (Jorge Mota-Pereira, Jose Carlos Ribeiro, Daniela Fonte, Serafim Carvalho, Joaquim Ramos, Jorge Silverio, Psychosocial Rehabilitation Department, Hospital Magalhaes Lemos, Porto, Portugal, and others)
Although there are several reports on the benefits of exercise on Major Depressive
Disorder, none has monitored these exercise programs with accelerometers. We have
conducted a 12 week home based moderate intensity exercise program in 33 treatmentresistant
Major Depressive Disorder patients and, based on accelerometer data,
determined compliance, exercise patterns and relationship between time spent in MVPA,
response to treatment and Quality of Life. Patients were diagnosed according to DSM-IV
criteria, and, from 150 initially screened, 33 met study criteria and were included. Four
patients were excluded due to non-compliance/drop-out, thus a total of 29 patients
finished the study. Patients were randomized either to a moderate intensity exercise
program, which consisted of 30-45 min/day walks, 5 days/week, for 12 weeks, plus usual
pharmacotherapy (N=22) or regular daily activities plus usual pharmacotherapy (N=11).
All participants wore an ActiGraph® GT1M accelerometer during the 12 weeks.
Moderate to very vigorous physical activity (MVPA), HAMD17, BDI, GAF, CGI-S,
WHOQOL-Bref and SF-36 were assessed. Results show a trend for increasing time spent
in MVPA from no response to response and remission (p = 0.028), and medium to strong
correlations between time spent in MVPA and better depression and functioning
parameters. There was also a trend for increasing time spent in MVPA and improvement
of some QoL domains, namely WHOQOL-Bref Physical domain and SF-36 Physical
Functioning and General Health Domains (p < 0.05). Participants showed preference for
exercising on weekdays and on specific periods of the day (p < 0.05). Therefore, we
suggest that future implementation of effective exercise augmentation therapy programs
in MDD patients should consider objective measures that allow the quantification of
exercise and assessment of exercise patterns. 

Available Options:

  Open Access item.
  Click below PDF icon for free download.


This is an Open Access item. Click above PDF icon for free download.
Special Focus Titles
01.Flavonoids in the Fight against Upper Gastrointestinal Tract Cancers
02.Resilience and Health: A Potent Dynamic
03.Alpha Lipoic Acid: New Perspectives and Clinical Use in Obstetrics and Gynecology
04.Advances in Psychobiology
05.Biodiversity in Time and Space
06.Multifaceted Autoethnography: Theoretical Advancements, Practical Considerations and Field Illustrations
07.Islam and Muslims in Europe
08.Violence Against Women in the 21st Century: Challenges and Future Directions
09.Challenges and Opportunities for Eurozone Governance
10.Flour: Production, Varieties and Nutrition
11.Liquid Metals: From Atomistic Potentials to Properties, Shock Compression, Earth's Core and Nanoclusters
12.Polyunsaturated Fatty Acids (PUFAs): Food Sources, Health Effects and Significance in Biochemistry

Nova Science Publishers
© Copyright 2004 - 2018

Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136)